Age-Related Macular Degeneration Therapeutics market

Age-Related Macular Degeneration (AMD) Therapeutics Market, Global Outlook and Forecast 2023-2030

22 November 2023
Life Sciences
65 Pages
Report code : PMR-7856569

4.7

(158)

Download Free PDF sample

Age-Related Macular Degeneration Therapeutics Market

Download FREE Report Sample

Download Free sample

Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.
Age-Related Macular Degeneration Therapeutics Market aims to provide a comprehensive presentation of the global market for Age-Related Macular Degeneration (AMD) Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Age-Related Macular Degeneration (AMD) Therapeutics. Age-Related Macular Degeneration Therapeutics Market contains market size and forecasts of Age-Related Macular Degeneration (AMD) Therapeutics in global, including the following market information:

Global Age-Related Macular Degeneration (AMD) Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)

The global Age-Related Macular Degeneration (AMD) Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Age-related macular degeneration is a progressive condition, and it is common among the geriatric population. The growing geriatric population is contributing to the rising incidence of age-related macular degeneration globally. As a result, there is a high demand for therapeutics to treat the condition. Pharmaceutical companies are leveraging this opportunity and are focusing on releasing drugs to treat age-related macular degeneration.
We surveyed the Age-Related Macular Degeneration (AMD) Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Age-Related Macular Degeneration (AMD) Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Age-Related Macular Degeneration (AMD) Therapeutics Market Segment Percentages, by Type, 2022 (%)

Wet AMD
Dry AMD

Global Age-Related Macular Degeneration (AMD) Therapeutics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Age-Related Macular Degeneration (AMD) Therapeutics Market Segment Percentages, by Application, 2022 (%)

Hospital
Clinic
Research Institute
Other

Global Age-Related Macular Degeneration (AMD) Therapeutics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Age-Related Macular Degeneration (AMD) Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)

North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

Key companies Age-Related Macular Degeneration (AMD) Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Age-Related Macular Degeneration (AMD) Therapeutics revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Amgen Inc.
Bausch Health Companies, Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.

Outline of Major Chapters:
Chapter 1: Introduces the definition of Age-Related Macular Degeneration (AMD) Therapeutics, market overview.
Chapter 2: Global Age-Related Macular Degeneration (AMD) Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Age-Related Macular Degeneration (AMD) Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Age-Related Macular Degeneration (AMD) Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

CHECK TODAYS BEST PRICE

Request
Chapter Price

Download
Free Sample

SECURITY ASSURED payment image

Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research

Frequently Asked Questions ?

User License

A license granted to one user.
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
Multi user License
A license granted to multiple users.
Site License
A license granted to a single business site/establishment.
Corporate License, Global License
A license granted to all employees within organisation access to the product.

Delivery Time

Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

WHY CHOOSE US

Proactive We manage our resources 24/7 to identify issues and address them before they become problems
Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach 6 Major regions and 40+ countries level analysis accomplished
Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Age-Related Macular Degeneration (AMD) Therapeutics Market, Global Outlook and Forecast 2023-2030

Age-Related Macular Degeneration Therapeutics Market

WHY CHOOSE US

SIMILAR REPORTS

Global Age-Related Macular Degeneration (AMD) Therapeutics Market Research Report 2024(Status and Outlook)

Global Age-Related Macular Degeneration (AMD) Therapeutics Market Research Report 2024(Status and Outlook)

Global Age-Related Macular Degeneration (AMD) Therapeutics Market Insights, Forecast to 2028

Quality Assurance

Trusted by the Best

Privacy and Security

Competitive Pricing